-
Canadian negotiator says 'more work to do' on US trade deal
-
Nakashima knocks out Fritz to reach Cincinnati semi-finals
-
'Solid' Clark takes solo lead at BMW Championship
-
Ukraine says 'cynical' Russian strike on shopping centre killed 16
-
Arteta hails Arsenal's desire after perfect start to title defence
-
TikTok to pay $400 mn settlement in US children's privacy case
-
Betis down Real Sociedad in La Liga opener
-
MLS fines Messi for striking an opponent
-
Mexican governor resumes job despite US drug charges
-
Gouiri double fires Marseille past Strasbourg in Ligue 1 opener
-
Arsenal rout Coventry to open Premier League season in style
-
Mavericks buy out Thompson, now reportedly bound for Heat
-
Giant-killer Bejlek overhauls Keys to reach Cincinnati semi-finals
-
England v Pakistan first Test: Three talking points
-
Man Utd agree deal for Brighton midfielder Baleba: reports
-
US, Canada push to seal trade deal as deadline nears
-
Werro wins Lausanne 800m, well off world record pace
-
One dead, three wounded after sword attack at Swedish high school
-
China mulls bid to host 2028 UN climate talks: sources
-
Ukraine says 'cynical' Russian strike on shopping centre killed 15
-
Jones becomes third Englishman to join Inter this summer
-
US Supreme Court allows White House ballroom construction for now
-
Mexican governor wanted on US drug charges returns to job
-
Root hails emerging fast bowlers as England thrash Pakistan
-
Bolivia's Paz forced to fire economy minister in mid-crisis
-
Brazil's Lula urges tariffs resolution in call with Trump
-
A-Rod ups T-Wolves stake in $4.5bn ownership change
-
Ukraine says 'cynical' Russian strike on shopping centre killed 14
-
UK court orders Prince Harry, others to pay Daily Mail initial £9.5mn
-
Heatwave-hit Europe logs over 30,000 excess summer deaths: first figures
-
'Grateful' ex-world champion Alaphilippe retires from cycling
-
Give LIV Golf 'one more shot,' says DeChambeau
-
US, Canada work to wrap up trade deal ahead of looming deadline
-
Duplantis hits the high notes for athletics anthem
-
Malaysia's JDT claim unbeaten run world record
-
Malaysia's JDT claims unbeaten run world record
-
At least 2 teens seriously wounded in sword attack at Swedish school
-
Bolivian economy minister fired after Congress vote
-
Popular forest near Paris to reopen after wildfire
-
Russell roars to Dutch GP sprint pole, Antonelli fifth
-
UN holds second informal poll of secretary-general candidates
-
Russell takes pole for Dutch GP sprint
-
Shakhtar Donetsk to play Champions League home games at Chelsea
-
England start life after Bazball with rout of Pakistan
-
Arsenal sign Villa centre-back Konsa as champions bolster defence
-
'Duck run' pest control catching on in S.Africa's winelands
-
The 'hedgehogs' leading Poland's defences on Russian border
-
UK, Canada, Australia slam Israel ending probe into aid worker killings
-
England thrash Pakistan by an innings and 103 runs in first Test
-
Spurs spending spree vital to raise standards: De Zerbi
NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets
ATHENS, GEORGIA / ACCESS Newswire / September 23, 2025 / Good Salt™ Life, Inc., a wholly owned subsidiary of NDT Pharmaceuticals Inc. (OTCID:NDTP) ("NDTP" or the "Company"), today shared insight into its strategic initiative designed to build value through investments in sustainable, science-driven health and wellness brands that protect people, pets, and the planet. Good Salt Life targets the $148 billion global biosafety market with a vertically integrated approach that combines proprietary hardware and EPA-approved antimicrobial solutions.
At the heart of Good Salt Life's innovation is hypochlorous acid (HOCl), a naturally occurring substance produced by the human body to combat infection. Through proprietary electrolysis, Good Salt Life transforms salt and water into powerful, eco-friendly solutions for home care, pet wellness, skincare, and professional biosafety. The Company's products are non-toxic, family-safe, and environmentally conscious, meeting the highest performance standards backed by EPA registration and rigorous third-party testing.
Trusted by Industry Leaders
Good Salt Life's breakthrough technologies have earned the trust of leading organizations across multiple sectors, including:
Animal Health: Strengthening welfare and biosecurity outcomes in critical environments to reduce mortality and ensure human health.
Cruise Industry: Partnering with industry giants such as Virgin, Royal Caribbean, Carnival Corp, and Norwegian Cruise Line to establish new benchmarks for passenger health and safety at sea.
Education & Healthcare: Providing solutions to renowned institutions like the Baptist Hospital System and Cleveland Clinic, ensuring the safety of vulnerable populations in hospitals and schools.
Government & Nonprofits: Offering proven solutions for maintaining hygiene in the Tennessee State Prison System, NY State Prison, New York City Fire Department, and Ronald McDonald House.
Sports: Collaborating with the New York Yankees, Boston Red Sox, Tampa Bay Rays, and NCAA programs including Ole Miss, Alabama, Clemson, LSU, and WKU Football to enhance safety and health standards.
Retail and E-Commerce: Expanding reach through partnerships with major distributors such as Amazon, Chewy, Walmart, Staples, Ecolox Tech, Imperial Dade, Veritiv, and System Chemical, making innovative products accessible to consumers.
Driving Scalable Impact
From households to large institutions, Good Salt Life's solutions are reshaping the meaning of cleanliness and protection. Whether reducing pathogens in animal shelters, safeguarding healthcare workers on the frontlines, or ensuring cruise passengers travel with peace of mind, Good Salt Life is scaling across markets where safety and sustainability are essential.
Investing in the Future
Good Salt Life is also focused on next-generation technologies that extend beyond chemistry. With advancements in robotics, AI-driven automation, and pioneering indoor air quality sensors, Good Salt Life is building a holistic ecosystem of safety solutions. These innovations will reduce labor costs, improve efficiency, and provide proactive protection against emerging health risks.
Commitment to Responsibility
"Good Salt Life stands at the intersection of innovation and responsibility," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "We are not just creating products; we are building a platform for healthier living, animal welfare, and environmental stewardship. As we grow alongside world-class partners and distributors, our vision remains clear: to lead the global shift toward safer, cleaner, and more sustainable living for future generations."
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, Inc.
Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
H.Thompson--AT